DK1567135T3 - Tiotropiumholdig pulverformulering til inhalation - Google Patents

Tiotropiumholdig pulverformulering til inhalation

Info

Publication number
DK1567135T3
DK1567135T3 DK03785648T DK03785648T DK1567135T3 DK 1567135 T3 DK1567135 T3 DK 1567135T3 DK 03785648 T DK03785648 T DK 03785648T DK 03785648 T DK03785648 T DK 03785648T DK 1567135 T3 DK1567135 T3 DK 1567135T3
Authority
DK
Denmark
Prior art keywords
tiotropium
inhalation
powder formulation
containing powder
formulation
Prior art date
Application number
DK03785648T
Other languages
Danish (da)
English (en)
Inventor
Mareke Hartig
Michael Walz
Michael Trunk
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32308760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1567135(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK1567135T3 publication Critical patent/DK1567135T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0001—Details of inhalators; Constructional features thereof
    • A61M15/0021—Mouthpieces therefor
    • A61M15/0025—Mouthpieces therefor with caps
    • A61M15/0026—Hinged caps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK03785648T 2002-11-28 2003-11-19 Tiotropiumholdig pulverformulering til inhalation DK1567135T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10255387A DE10255387A1 (de) 2002-11-28 2002-11-28 Neue Tiotropium-haltige Pulverformulierung für die Inhalation
PCT/EP2003/012911 WO2004047796A2 (de) 2002-11-28 2003-11-19 Neue tiotropium-haltige pulverformulierung für die inhalation

Publications (1)

Publication Number Publication Date
DK1567135T3 true DK1567135T3 (da) 2008-10-27

Family

ID=32308760

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03785648T DK1567135T3 (da) 2002-11-28 2003-11-19 Tiotropiumholdig pulverformulering til inhalation

Country Status (34)

Country Link
EP (1) EP1567135B1 (pt)
JP (1) JP4977321B2 (pt)
KR (1) KR101066805B1 (pt)
CN (1) CN100574751C (pt)
AR (1) AR042242A1 (pt)
AT (1) ATE401861T1 (pt)
AU (1) AU2003294714B2 (pt)
BR (1) BR0316343A (pt)
CA (1) CA2507579C (pt)
CO (1) CO5580736A2 (pt)
CY (1) CY1108420T1 (pt)
DE (2) DE10255387A1 (pt)
DK (1) DK1567135T3 (pt)
EA (1) EA011549B1 (pt)
EC (1) ECSP055821A (pt)
ES (1) ES2310681T3 (pt)
HK (1) HK1085918A1 (pt)
HR (1) HRP20050468A2 (pt)
IL (1) IL168810A (pt)
ME (1) MEP51608A (pt)
MX (1) MXPA05005485A (pt)
MY (1) MY140890A (pt)
NO (1) NO20053090L (pt)
PE (1) PE20040848A1 (pt)
PL (1) PL376229A1 (pt)
PT (1) PT1567135E (pt)
RS (1) RS20050400A (pt)
SA (1) SA04240467B1 (pt)
SI (1) SI1567135T1 (pt)
TW (1) TWI332837B (pt)
UA (1) UA81930C2 (pt)
UY (1) UY28096A1 (pt)
WO (1) WO2004047796A2 (pt)
ZA (1) ZA200502859B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102008014025A1 (de) * 2008-03-13 2009-09-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator und Sieb für einen Inhalator
TR200909788A2 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Tiotropyum içeren inhalasyona uygun kuru toz formülasyonu
PE20130601A1 (es) * 2010-08-03 2013-05-30 Chiesi Farma Spa Formulacion de polvo seco que comprende un inhidor de fosfodiesterasa
WO2014074797A1 (en) * 2012-11-09 2014-05-15 Civitas Therapeutics, Inc. Ultra low density pulmonary powders
KR101748796B1 (ko) * 2015-09-30 2017-06-19 한미약품 주식회사 활성성분의 전달량이 향상된 흡입용 캡슐제
KR101728116B1 (ko) * 2015-11-03 2017-04-18 한미약품 주식회사 티오트로피움 또는 이의 약학적으로 허용가능한 염을 함유하는 흡입용 건조분말 조성물
CN111514418B (zh) * 2019-06-12 2022-01-14 中南大学湘雅二医院 一种自吸式经鼻粉末材料给送装置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1242211A (en) * 1967-08-08 1971-08-11 Fisons Pharmaceuticals Ltd Pharmaceutical composition
DE4140689B4 (de) * 1991-12-10 2007-11-22 Boehringer Ingelheim Kg Inhalationspulver und Verfahren zu ihrer Herstellung
DE4318455A1 (de) * 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
GB9322014D0 (en) * 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
DE4425255A1 (de) * 1994-07-16 1996-01-18 Asta Medica Ag Formulierung zur inhalativen Applikation
SK284889B6 (sk) * 1998-11-13 2006-02-02 Jago Research Ag Použitie stearátu horečnatého v suchých práškových formuláciách na inhaláciu
GB9902689D0 (en) * 1999-02-08 1999-03-31 Novartis Ag Organic compounds
UA75375C2 (en) * 2000-10-12 2006-04-17 Boehringer Ingelheim Pharma Method for producing powdery preparations for inhaling
DZ3477A1 (pt) * 2000-10-12 2002-04-18
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10141377A1 (de) * 2001-08-23 2003-03-13 Boehringer Ingelheim Pharma Aufstreuverfahren zur Herstellung von Pulverformulierungen
WO2003084509A1 (en) * 2002-04-04 2003-10-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powder formulations suitable for inhalation
UA80123C2 (en) * 2002-04-09 2007-08-27 Boehringer Ingelheim Pharma Inhalation kit comprising inhalable powder of tiotropium

Also Published As

Publication number Publication date
CA2507579C (en) 2011-07-19
JP2006510622A (ja) 2006-03-30
EA011549B1 (ru) 2009-04-28
CA2507579A1 (en) 2004-06-10
TWI332837B (en) 2010-11-11
ES2310681T3 (es) 2009-01-16
PT1567135E (pt) 2008-09-01
TW200500066A (en) 2005-01-01
CN1717225A (zh) 2006-01-04
SI1567135T1 (sl) 2008-10-31
PE20040848A1 (es) 2005-01-14
CY1108420T1 (el) 2014-04-09
ECSP055821A (es) 2005-08-11
KR20050086887A (ko) 2005-08-30
WO2004047796A2 (de) 2004-06-10
KR101066805B1 (ko) 2011-09-22
CN100574751C (zh) 2009-12-30
NO20053090D0 (no) 2005-06-23
NO20053090L (no) 2005-06-23
AU2003294714A1 (en) 2004-06-18
HRP20050468A2 (en) 2006-07-31
EP1567135A2 (de) 2005-08-31
MY140890A (en) 2010-01-29
CO5580736A2 (es) 2005-11-30
AR042242A1 (es) 2005-06-15
UY28096A1 (es) 2004-06-30
WO2004047796A3 (de) 2004-09-30
DE50310208D1 (de) 2008-09-04
ZA200502859B (en) 2006-02-22
DE10255387A1 (de) 2004-06-09
JP4977321B2 (ja) 2012-07-18
EA200500864A1 (ru) 2006-02-24
ATE401861T1 (de) 2008-08-15
AU2003294714B2 (en) 2009-10-08
RS20050400A (en) 2007-04-10
PL376229A1 (en) 2005-12-27
BR0316343A (pt) 2005-09-27
UA81930C2 (uk) 2008-02-25
EP1567135B1 (de) 2008-07-23
SA04240467B1 (ar) 2008-10-15
MXPA05005485A (es) 2005-07-25
IL168810A (en) 2015-02-26
MEP51608A (en) 2011-02-10
HK1085918A1 (en) 2006-09-08

Similar Documents

Publication Publication Date Title
DE60211507D1 (de) Pulverinhalator
ATE331550T1 (de) Trockenpulverinhalator
DK3536344T3 (da) Superfin formoterolformulering
DK1615646T4 (da) Farmaceutiske formuleringer, der indeholder methylnaltrexon
PT1501534E (pt) Formulacoes farmaceuticas
DK1689360T3 (da) Tørpulverformuleringer
DE60315872D1 (de) Pulverlack
DE60310914D1 (de) Pulverzusammensetzung
NO20035442D0 (no) Pulverlakksammensetning
IS7501A (is) thurrdufts innöndunar samsetning
ATE369139T1 (de) Hochdosierte ibandronat-formulierung
DK1382947T3 (da) Doseringsanlæg til pulverpigmenter
DK1539089T3 (da) Reducerede aerosol-genererende formuleringer
HUP0303948A2 (hu) Szájban diszpergálódó szilárd gyógyszerforma
NO20053090D0 (no) Pulverformulering for innhalering inneholdende tiotropium.
GB0316206D0 (en) Pharmaceutical formulation
IS7500A (is) thurrdufts samsetningar
PT1496876E (pt) Formulação de aerossol para a inalação contendo brometo de tiotrópio
NO20043489L (no) Sammensetning for inhalering
DE602004004266D1 (de) Pulverspender
GB0303876D0 (en) Formulation
NO20044164L (no) Farmasoytiske sammensetninger
GB0310881D0 (en) Pharmaceutical formulation
AU2003238900A8 (en) Pharmaceutical formulation
SE0201660D0 (sv) Pharmaceutical formulation